富士製薬工業株式会社
Ranked #992 among listed Japanese companies by corporate taxes paid · effective tax rate 25.0%.
Share price at fiscal year-end: ¥1,545 · market capitalization ¥38.5B · P/E 12.6 · P/B 0.82
US dollar amounts use ¥157.8 per dollar.
| Fiscal year | Revenue | Net income | Tax expense | Taxes paid | Total assets | Net assets | Equity ratio | Source |
|---|---|---|---|---|---|---|---|---|
| Sep 2025 | ¥51.7B | ¥3.0B | ¥1.0B | ¥2.2B | ¥93.4B | ¥46.9B | 50.2% | EDINET (consol.) |
| Sep 2024 | ¥46.1B | ¥6.1B | ¥2.1B | ¥1.0B | ¥90.0B | ¥45.6B | 50.6% | EDINET (consol.) |
| Sep 2023 | ¥40.9B | ¥3.4B | — | — | ¥85.3B | ¥41.2B | 48.3% | EDINET (consol.) |
| Sep 2022 | ¥35.4B | ¥2.7B | — | — | ¥75.5B | ¥35.8B | 47.4% | EDINET (consol.) |
| Sep 2021 | ¥34.0B | ¥2.4B | — | — | ¥64.2B | ¥32.7B | 50.9% | EDINET (consol.) |
From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）
See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.